Glucagon agonism adds energy expenditure and liver-fat reduction signals
Beyond those standing concerns, in a press announcement dated March 3, 2026 (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products
Contact Us Monday: Array Tuesday: Array Wednesday: Array Thursday: Array Friday: Array Saturday: Array Sunday: Array
If exposure has occurred, you need to assess the degree of damage based on temperature reached and duration, not simply refrigerate and hope for the best
NEWSLETTER SIGNUP Product launch information, promotions, blogs, and REP news.